SABS SAB Biotherapeutics: Narxning prognoz qilingan daromadga nisbati
SAB Biotherapeutics (SABS) samaradorligi bio-aktivlar ustidan nazoratni saqlagan holda tashqi laboratoriyalar bilan hamkorlikka asoslangan. GURU.Markets servisida kelgusi daromad koeffitsienti 1668.60 yangi darajani qayd etgan chiziqli grafik taqdim etilgan. Bu diabetga qarshi antitanalarni yaratishda platformaning moslashuvchanligini tasdiqlaydi, garchi yuqori ishlab chiqarish xarajatlari va yakuniy sinovlarda FDA tomonidan yuzaga kelishi mumkin bo'lgan kechikishlar tufayli moliyaviy barqarorlik zaif bo'lib qolayotgan bo'lsa-da.
SAB Biotherapeutics Inc (SABS) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Umumiy qarzning xususiy kapitalga nisbati SAB Biotherapeutics|SABS - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati SAB Biotherapeutics|SABS - Kompaniya qarzlari|Balans kapitallashuviga qarzlar SAB Biotherapeutics Inc|SABS - Uzoq muddatli qarz hajmi|Kompaniyaning qisqa muddatli qarzi SAB Biotherapeutics|Tezkor likvidlik ko‘rsatkichi sabbiotherapeutics.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
SABS - Soliqlar to‘langandan keyingi foyda|Prognoz qilingan kelajakdagi foyda SAB Biotherapeutics|SABS - Kompaniya qiymatining sof foydaga nisbati|Forvard P/E multiplikatori SAB Biotherapeutics, Inc|SABS - O‘sish sur’atiga tuzatilgan narx-foyda|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati SAB Biotherapeutics Inc|SABS - Foizlar, soliqlar va amortizatsiya chegirilmasdan oldingi daromad|Bir aksiya uchun sof foyda (EPS TTM) SAB Biotherapeutics|SABS - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi sabbiotherapeutics.com|SABS - Joriy yilda bir aksiya uchun foyda dinamikasi|Keyingi yil uchun foyda o'sishi prognozi SAB Biotherapeutics
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning jamlanma tahliliyoti:SAB Biotherapeutics, Inc. SABS
Forward P/S koeffitsiyenti aktivning bozor qiymatini prognoz qilingan daromadga nisbatan baholaydi, bu esa investorlarga kutilayotgan savdo o'sishi uchun to'langan premium miqdorini aniqlash imkonini beradi. GURU.Markets platformasida prognoz qilingan P/S multiplikatorini tahlil qilish orqali investor SAB Biotherapeutics (SABS) kompaniyasi uchun spekulyativ qizib ketishni aniqlay oladi, bu esa kapitalizatsiyasi bevosita klinik sinovlar natijalari va FDA tasdiqlashlariga bog'liq bo'lgan antitelalar ishlab chiquvchisi uchun juda muhimdir.
Raqobatdosh kompaniyalar tahlili
Forvard P/S multiplikatori ARGX (argenx)|BioNTech Inc. (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|ABVX - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning kutilayotgan sotuvga nisbati ADMA Corp ADMA|PTGX: Forvard P/S multiplikatori|immunovant.com (IMVT) - Forvard P/S multiplikatori|KNSA (Kiniksa) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati GRFS|Forvard narx/daromad multiplikatori ADPT (Adaptive Biotechnologies Corp)|CLDX (Celldex Corp) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori AUPH (Aurinia Pharmaceuticals)|biocryst.com - Narxning prognoz qilingan daromadga nisbati|Vera Therapeutics - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Dianthus Therapeutics Inc DNTH|Pharvaris Corp (PHVS) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati AbCellera Corp (ABCL)|Forvard narx/daromad multiplikatori TRML|PGEN (precigen.com) - Narxning kutilayotgan daromadga nisbati|Forvard P/S multiplikatori PHAR|NKTR (Nektar Therapeutics Inc) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori UPB (Upstream Bio Corp)|Zenas Corp (ZBIO) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|IMNM - Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx GOSS (gossamerbio.com)|KALV: Forvard P/S multiplikatori|Septerna, Inc. (SEPN) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Pieris Pharmaceuticals Inc|Savara Pharma - Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori RIGL|ANAB - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Astria Therapeutics, Inc. - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori enGene Holdings Inc ENGN|RAPT: Forvard narx/daromad multiplikatori|Aerovate Therapeutics Inc - Narxning kutilayotgan daromadga nisbati|ACRS: Forvard P/S multiplikatori|KYTX - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|TLSA (Tiziana Life Sciences Ltd) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Cabaletta Bio Inc. (CABA)|Narxning prognoz qilingan daromadga nisbati Ventyx Bio (VTYX)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Theratechnologies, Inc|Narxning prognoz qilingan daromadga nisbati Avalo Therapeutics, Inc AVTX|Kapitalizatsiyaning kutilayotgan sotuvga nisbati eledon.com (ELDN)|Agenus Inc. - Forvard P/S multiplikatori|CLYM - Forvard P/S multiplikatori|ZURA: Forvard P/S multiplikatori|ATYR (aTyr Pharmaceuticals) - Narxning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Adagene Inc|Ikena Oncology, Inc. (IMA) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Shattuck Labs, Inc. (STTK)|EQ: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori CNTB (Connect Biopharma Holdings Limited)|Sotuvga nisbatan forvard narx IMUX|Atara Biotherapeutics Inc - Forvard P/S multiplikatori|IFRX - Forvard P/S multiplikatori|X4 Pharmaceuticals, Inc. (XFOR) - Narxning prognoz qilingan daromadga nisbati|Adicet Bio, Inc. - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Celularity Inc|Forvard narx/daromad multiplikatori INmune Bio Corporation (INMB)|Forvard P/S multiplikatori BRNS|Forvard P/S multiplikatori kezarlifesciences.com (KZR)|Akari Therapeutics Plc - Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx ENLV|Q32 Bio Corp - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati GeoVax Corp GOVX|Edesa Biotech, Inc. (EDSA) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori ibioinc.com|Narxning prognoz qilingan daromadga nisbati Carisma Therapeutics Inc|Forvard narx/daromad multiplikatori XTL Biopharmaceuticals Ltd (XTLB)|Forvard narx/daromad multiplikatori BOLT (Bolt Biotherapeutics)|Forvard P/S multiplikatori hcwbiologics.com (HCWB)|Narxning prognoz qilingan daromadga nisbati Aptevo Therapeutics Inc. APVO|AIM: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Aditxt Corp - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati GRI Bio Inc|XORTX (XRTX) - Narxning prognoz qilingan daromadga nisbati|HIND - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|REVB (Revelation Biosciences) - Forvard P/S multiplikatori|Forvard P/S multiplikatori indaptusrx.com|Forvard P/S multiplikatori SCNI|Narxning prognoz qilingan daromadga nisbati CALI (calcimedica.com)|Affimed N.V. - Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx ALLK|HOOKIPA - Forvard P/S multiplikatori|IGMS: Narxning prognoz qilingan daromadga nisbati|ITOS: Forvard P/S multiplikatori|OCEA - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati TC BioPharm (Holdings) PLC|Bozor kapitallashuvining kelajakdagi daromadga nisbati Third Harmonic Bio Inc THRD
